This report provides an in-depth analysis of Zepp Health Corporation's (NYSE: ZEPP) Q3-2024 performance, highlighting a 4% QoQ revenue increase but a 49% YoY decline due to lower unit sales and product discontinuations. The report examines the launch of the T-Rex 3 smartwatch, supply chain constraints, and Zepp's competitive positioning in the global smartwatch market. It also discusses management's optimistic Q4 guidance, industry trends, and the valuation discrepancy between Zepp's market cap ...
Yesterday, we hosted a call with Jeremy Woodlee, CEO of Santa Ynez Partners, a boutique advisory firm focused on digital media and ad tech. Previously, he spent three years at Accenture leading its global relationship with Google Ads after spending 11 years at Google, and three years at Magnite (fka Rubicon Project).
We have updated our estimates for Amazon Web Services (AWS) and Google Cloud Platform’s (GCP) revenues from AI products and services after updating our installed base in our AI Capex update last week (see HERE), and more importantly, new pricing information we found on the AWS and GCP websites.
Yesterday, we hosted an expert call with NSR’s Blair Levin and Pierre Ferragu about the state of antitrust activities versus Big Tech, including GOOGL and META. We also reviewed the potential actions of the incoming Trump administration and how the approach to antitrust may change.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.